Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07481214 · ClinicalTrials.gov registry record · NA
Lupus Walking Intervention to Address Fatigue/Quality of Life
A NA study of System Lupus Erythematosus(SLE), sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT07481214 is a NA study of System Lupus Erythematosus(SLE) that has completed, run by University of California, San Francisco. The registered enrollment target is 101 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07481214, a NA study of System Lupus Erythematosus(SLE), has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Fatigue is a major concern to individuals with lupus, persisting even when disease activity is clinically minimal, and impacting almost all quality of life domains. Studies show cross-sectional correlations between fatigue and physical activity levels in lupus. Some previous physical activity interventions have been tested in lupus and shown modest, although inconsistent, effects on fatigue. However, all of these interventions have been resource-intensive, requiring structured activities or special facilities, increasing barriers to access, dissemination, and widespread implementation. Focus Area: Improving quality of life for individuals living with lupus, with emphasis on symptom control and challenges that when addressed make day-to-day living with lupus easier and life more fulfilling. Objective and Hypotheses: The proposed study will test a simple pedometer-based walking intervention, based on an intervention previously implemented in rheumatoid arthritis with successful results in reducing fatigue. The intervention will address weaknesses in previous physical activity interventions in lupus that may have limited their impact. Hypothesis 1: Individuals in the intervention arm will achieve greater increases in physical activity than individuals in the control group. Hypothesis 2a: Individuals in the intervention arm will experience greater reductions in fatigue compared to baseline than the control group. Hypothesis 2b: Individuals in the intervention arm will experience greater improvements in other domains of quality of life (e.g., pain interference, perceived cognitive function, sleep disturbance, depression, anxiety) compared to baseline than the control group Hypothesis 2c: Greater increases in activity will be associated with greater reductions in fatigue and improvements in other domains of quality of life. Specific Aims Aim 1: Test the impact of a pedometer-based physical activity intervention on activity levels in persons with systemic
Conditions Studied
Interventions
- BEHAVIORAL guided increases in daily walking
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07481214
The ClinicalTrials.gov registry entry for NCT07481214 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with System Lupus Erythematosus(SLE) appearing as the primary indexed condition, and to 1 intervention - of which guided increases in daily walking is the first listed.
NCT07481214 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07481214 about?
NCT07481214 is a clinical study titled "Lupus Walking Intervention to Address Fatigue/Quality of Life". Background: Fatigue is a major concern to individuals with lupus, persisting even when disease activity is clinically minimal, and impacting almost all quality of life domains. Studies show cross-sectional correlations between fatigue and physical activity levels in lupus. Some previous physical act...
What is the current status of trial NCT07481214?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2022-07-01. Estimated completion is 2025-12-15.
What conditions does trial NCT07481214 study?
This clinical trial studies the following conditions: System Lupus Erythematosus(SLE).
What interventions are being tested in trial NCT07481214?
The interventions under investigation include: guided increases in daily walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT07481214?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07481214 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.